Is the Worst Over for Illumina Stock?
With shares of the gene sequencing giant Illumina (NASDAQ: ILMN) collapsing by 53% over the last three years due to a combination of a botched acquisition attempt and weakness in its core business, shareholders are doubtlessly wondering whether the stock's decline is finished, or if it's just getting started.
With the naming of a new chief technology officer (CTO) on August 9 and a new CEO on September 5, at a minimum investors can have confidence that something about the company's strategy is going to change. But it's also easy to envision a failed attempt at a turnaround.
So let's ask whether the worst is over given what we know right now.
Source Fool.com
Illumina Inc. Stock
€100.50
1.410%
Our community is currently high on Illumina Inc. with 19 Buy predictions and 4 Sell predictions.
As a result the target price of 169 € shows a very positive potential of 68.16% compared to the current price of 100.5 € for Illumina Inc..
